Shire plc
Jump to navigation
Jump to search
Shire is a Jersey-registered, Irish-headquartered specialty biopharmaceutical company, owned by Japan's Takeda Pharmaceutical Company Ltd since Jan.2019.
Shire is a neuroscience specialist, well-known for its products for Attention Deficit Hyperactivity disorder, such as Vyvanse, Lialda, and Adderall XR. The company‘s biggest market is the USA.
Corporate Political Engagement Rating:[1] Transparency International B
Company
Ownership
Structure
- Shire Ltd, was Shire plc, OC
- Baxalta UK Ltd, [CH]
- Shire Pharmaceuticals Ltd, [CH]
- Shire Biotech UK Holdings Ltd, [CH]
- Shire Investments & Finance (UK) Company, [CH]
- Shire US Investments, [CH]
- Lumena Pharma UK Ltd, [CH]
- Baxalta UK Ltd, [CH]
Timeline
May.2018 | Takeda Pharmaceutical Company Ltd acquired Shire, after some weeks of haggling.[2] The acquisition completed in Jan.2019, at which point Shire was delisted and taken private.[3] |
Articles
- Oct.14.2014: Tax Reform in the UK Reversed the Tide of Corporate Tax Inversions. Because the European Union allows capital to move as freely between the member states as it moves among the 50 US states, more than a dozen British multinational firms chose to move their headquarters to countries with more favorable tax climates to protect their foreign earnings from the UK tax code. WPP moved to Ireland. United Business Media moved to Ireland. Henderson Group plc moved to Ireland. Shire plc moved to Ireland. Informa plc moved to Switzerland. Regus Group plc moved to Luxembourg. Charter International plc moved to Ireland. Brit plc moved to the Netherlands. William McBride, Tax Foundation.
References
- ^ Corporate Political Engagement Index 2018. The new index of 104 multi-national companies, many of whom regularly meet with govt, has found nearly 75% are failing to adequately disclose how they engage with politicians. Only one company received the highest grade, with the average grade being "E" – representing poor standards in transparency. Transparency International UK, Nov.2018.
- ^ Takeda to hold talks over Shire deal. Alex Ralh, The Times, Apr.25.2018.
- ^ Takeda completes Shire acquisition. PharmaTimes, Jan.08.2019.